Neurobehavioral changes associated with bilateral caudate nucleus infarctions.
Narumoto
Jin
J
Matsushima
Nobuko
N
Oka
Syogo
S
Shimizu
Hiroshi
H
Kooguchi
Yukiko
Y
Kitabayashi
Yurinosuke
Y
Kunizawa
Masahiro
M
Ueda
Hideki
H
Fukui
Kenji
K
D020144:Basal Ganglia Cerebrovascular Disease / Q000175:diagnosis / Q000188:drug therapy / Q000503:physiopathology*; D002421:Caudate Nucleus / Q000187:drug effects / Q000473:pathology / Q000503:physiopathology; D002540:Cerebral Cortex / Q000187:drug effects / Q000473:pathology / Q000503:physiopathology; D002544:Cerebral Infarction / Q000175:diagnosis / Q000188:drug therapy / Q000503:physiopathology*; D003702:Delusions / Q000175:diagnosis / Q000188:drug therapy / Q000503:physiopathology; D004292:Dominance, Cerebral / Q000502:physiology*; D005260:Female; D006212:Hallucinations / Q000175:diagnosis / Q000188:drug therapy / Q000503:physiopathology; D006220:Haloperidol / Q000627:therapeutic use; D006801:Humans; D008570:Memory, Short-Term / Q000187:drug effects / Q000502:physiology; D001523:Mental Disorders / Q000175:diagnosis / Q000188:drug therapy / Q000503:physiopathology*; D008609:Mental Status Schedule; D008875:Middle Aged; D009042:Motivation; D009434:Neural Pathways / Q000187:drug effects / Q000473:pathology / Q000503:physiopathology; D009483:Neuropsychological Tests; D013064:Speech Disorders / Q000175:diagnosis / Q000188:drug therapy / Q000503:physiopathology; D013788:Thalamus / Q000187:drug effects / Q000473:pathology / Q000503:physiopathology; D014057:Tomography, X-Ray Computed
D006220:Haloperidol